These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus. Suzuki K Ther Apher; 2000 Jun; 4(3):239-43. PubMed ID: 10910027 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in therapeutic apheresis. Bosch T J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117 [TBL] [Abstract][Full Text] [Related]
29. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Wallukat G; Reinke P; Dörffel WV; Luther HP; Bestvater K; Felix SB; Baumann G Int J Cardiol; 1996 May; 54(2):191-5. PubMed ID: 8803685 [TBL] [Abstract][Full Text] [Related]
31. New trends in specific immunoadsorption. Ullrich H; Kuehnl P Transfus Apher Sci; 2004 Jun; 30(3):223-31. PubMed ID: 15172628 [TBL] [Abstract][Full Text] [Related]
32. Immunoadsorption in dermatology. Meyersburg D; Schmidt E; Kasperkiewicz M; Zillikens D Ther Apher Dial; 2012 Aug; 16(4):311-20. PubMed ID: 22817118 [TBL] [Abstract][Full Text] [Related]
33. Detection of antibodies in eluates of immunoadsorption causing humoural rejection in patients after solid organ transplantation. Barz D; Rummler S Atheroscler Suppl; 2013 Jan; 14(1):191-7. PubMed ID: 23357164 [TBL] [Abstract][Full Text] [Related]
34. The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection. Ahmed T; Senzel L J Clin Apher; 2012; 27(4):173-7. PubMed ID: 22411078 [TBL] [Abstract][Full Text] [Related]
35. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies. Christ T; Dobrev D; Wallukat G; Schüler S; Ravens U Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):141-4. PubMed ID: 11523313 [TBL] [Abstract][Full Text] [Related]
36. Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia. Stefanutti C; Di Giacomo S; Mareri M; De Lorenzo F; D'Alessandri G; Angelico F; Bucci A; Musca A; Mammarella A Transfus Apher Sci; 2003 Jun; 28(3):207-14. PubMed ID: 12725944 [TBL] [Abstract][Full Text] [Related]
37. Removal of pathogenic autoantibodies by immunoadsorption. Hershko AY; Naparstek Y Ann N Y Acad Sci; 2005 Jun; 1051():635-46. PubMed ID: 16127004 [TBL] [Abstract][Full Text] [Related]
38. Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells. Opgenoorth M; Wagner A; Passauer J; Hohenstein B; Hugo C Atheroscler Suppl; 2015 May; 18():67-73. PubMed ID: 25936307 [TBL] [Abstract][Full Text] [Related]
39. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165 [TBL] [Abstract][Full Text] [Related]
40. New ligand coupling procedure for formation of an immunoadsorption wall. Yang TH; Feng CL ASAIO J; 2007; 53(2):201-6. PubMed ID: 17413561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]